Video

In Small Stroke Patient Group TEMPO-1 Trial Shows Early Promise

Author(s):

Patients who come to a hospital following a stroke face a variety of challenges and complications. A recent study looked at a possible treatment for those who suffered only a mild or moderate stroke.

Patients who come to a hospital following a stroke face a variety of challenges and complications. A recent study looked at a possible treatment for those who suffered only a mild or moderate stroke.

Shelagh Coutts, MB, ChB, from the University of Calgary discussed the results of the TEMPO-1 Trial while at the International Stroke Conference in Nashville.

Related Videos
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Experts' Perspectives: Top Stories in Cardiology for 2024
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
© 2025 MJH Life Sciences

All rights reserved.